Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Role of Baseline Sarcopenia in Determining Acute Toxicity for Head and Neck Cancer Patients Treated with Curative Hadrontherapy: a Prospective Monoinstitutional Study

Authors not listed

CNAO National Center of Oncological Hadrontherapy · 2023

Abstract

The study focuses on the impact of sarcopenia on acute and late toxicities in head and neck tumor affected patients treated with particle therapy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-07 MST

Cite this

APA
Anonymous. (2023). Role of Baseline Sarcopenia in Determining Acute Toxicity for Head and Neck Cancer Patients Treated with Curative Hadrontherapy: a Prospective Monoinstitutional Study. <em>CNAO National Center of Oncological Hadrontherapy</em>. https://clinicaltrials.gov/study/NCT06207708
Vancouver
Anonymous. Role of Baseline Sarcopenia in Determining Acute Toxicity for Head and Neck Cancer Patients Treated with Curative Hadrontherapy: a Prospective Monoinstitutional Study. CNAO National Center of Oncological Hadrontherapy. 2023.
BibTeX
@misc{anon2023Roleof, title = {Role of Baseline Sarcopenia in Determining Acute Toxicity for Head and Neck Cancer Patients Treated with Curative Hadrontherapy: a Prospective Monoinstitutional Study}, author = {Anonymous}, journal = {CNAO National Center of Oncological Hadrontherapy}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings